Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Targeting therapy to the fibrin-mediated pathophysiology of acute coronary syndrome.

White H.

Clin Appl Thromb Hemost. 2014 Jul;20(5):516-23. doi: 10.1177/1076029612472551. Epub 2013 Jan 23. Review.

PMID:
23344993
2.

Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome.

Weitz JI.

Thromb Haemost. 2014 Nov;112(5):924-31. doi: 10.1160/TH14-03-0265. Epub 2014 Jul 17. Review.

PMID:
25030773
3.

Antiplatelet intervention in acute coronary syndrome.

Arora RR, Rai F.

Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238. Review.

PMID:
19092648
4.

Targeting thrombin long-term after an acute coronary syndrome: Opportunities and challenges.

De Caterina R, Goto S.

Vascul Pharmacol. 2016 Jun;81:1-14. doi: 10.1016/j.vph.2016.03.003. Epub 2016 Mar 16. Review.

PMID:
26994821
5.

Antiplatelet therapy in acute coronary syndromes.

Barker CM, Price MJ.

Curr Cardiol Rep. 2008 Jul;10(4):327-33.

PMID:
18611368
6.

Emerging oral antiplatelet therapies for acute coronary syndromes.

Pollack CV Jr.

Hosp Pract (1995). 2010 Nov;38(4):29-37. doi: 10.3810/hp.2010.11.337.

PMID:
21068524
7.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
8.

Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.

Ganetsky VS, Hadley DE, Thomas TF.

Pharmacotherapy. 2014 Jun;34(6):590-604. doi: 10.1002/phar.1375. Epub 2013 Dec 13. Review.

PMID:
24338703
9.

Oral antiplatelet therapy for acute coronary syndromes: aspirin, P2Y12 inhibition and thrombin receptor antagonists.

Bailey AL, Campbell CL.

Curr Drug Targets. 2011 Nov;12(12):1805-12. Review.

PMID:
21718239
10.

Novel oral anticoagulants in acute coronary syndrome.

Costopoulos C, Niespialowska-Steuden M, Kukreja N, Gorog DA.

Int J Cardiol. 2013 Sep 10;167(6):2449-55. doi: 10.1016/j.ijcard.2012.08.014. Epub 2012 Sep 16. Review.

PMID:
22989603
11.

Antithrombotic therapy in patients with acute coronary syndromes: how to make the right choice?

Eitan A, Nikolsky E.

Minerva Med. 2013 Aug;104(4):357-81. Review.

PMID:
24008600
12.
13.

Management of acute coronary syndrome in the hospital: a focus on ACCF/AHA guideline updates to oral antiplatelet therapy.

Vengoechea F.

Hosp Pract (1995). 2014 Aug;42(3):33-47. doi: 10.3810/hp.2014.08.1116. Review.

PMID:
25255405
14.

Improving long-term ACS management: is there a role for the new antiplatelets?

Cohen M.

J Interv Cardiol. 2012 Oct;25(5):425-32. doi: 10.1111/j.1540-8183.2012.00738.x. Epub 2012 May 11. Review.

PMID:
22574644
15.

Managing the acute coronary syndrome patient: Evidence based recommendations for anti-platelet therapy.

Clark MG, Beavers C, Osborne J.

Heart Lung. 2015 Mar-Apr;44(2):141-9. doi: 10.1016/j.hrtlng.2014.11.005. Epub 2015 Jan 13. Review.

PMID:
25592204
16.

Advances in antiplatelet therapy for ACS and PCI.

Moliterno DJ.

J Interv Cardiol. 2008 Dec;21 Suppl 1:S18-24. doi: 10.1111/j.1540-8183.2008.00409.x. Review.

PMID:
19090933
17.

Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agents.

Angiolillo DJ, Ferreiro JL.

Am J Cardiovasc Drugs. 2013 Aug;13(4):233-50. doi: 10.1007/s40256-013-0022-7. Review.

PMID:
23613159
18.

Direct oral anticoagulants in acute coronary syndrome.

Ahrens I, Bode C.

Semin Hematol. 2014 Apr;51(2):147-51. doi: 10.1053/j.seminhematol.2014.03.004. Epub 2014 Mar 29.

PMID:
24861799
19.

Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.

Vermeer NS, Bajorek BV.

J Clin Pharm Ther. 2008 Dec;33(6):591-601. doi: 10.1111/j.1365-2710.2008.00950.x.

PMID:
19138236
20.

Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome.

Viswanathan GN, Marshall SM, Balasubramaniam K, Badimon JJ, Zaman AG.

Thromb Res. 2014 May;133(5):880-5. doi: 10.1016/j.thromres.2014.01.033. Epub 2014 Feb 1.

Supplemental Content

Support Center